This is the authors' abstract. We don't add key points for this paper.
Here we show that patients with myelodysplastic syndromes (MDS) have a severe deficiency of glycolipid reactive Valpha24+/Vbeta11+ natural killer T (NKT) cells, but not NK cells or CD4+ or CD8+ T cells. Neither the blood nor marrow of MDS patients had detectable interferon-gamma-producing NKT cells in response to the NKT ligand, alpha-galactosyl ceramide, although influenza-virus-specific effector T-cell function was preserved. This severe and selective deficiency of an important immune regulatory cell may contribute to the pathogenesis of MDS.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Fujii et al. (2003) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: